90 related articles for article (PubMed ID: 1528947)
1. Opioid-dopaminergic mechanisms in the potentiation of d-amphetamine discrimination by interferon-alpha.
Ho BT; Huo YY; Lu JG; Tansey LW; Levin VA
Pharmacol Biochem Behav; 1992 May; 42(1):57-60. PubMed ID: 1528947
[TBL] [Abstract][Full Text] [Related]
2. The opioid mechanism of interferon-alpha action.
Ho BT; Lu JG; Huo YY; Fan SH; Meyers CA; Tansey LW; Payne R; Levin VA
Anticancer Drugs; 1994 Feb; 5(1):90-4. PubMed ID: 8186436
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical basis of interleukin 2-modified discrimination behaviour.
Ho BT; Lu JG; Huo YY; Fan SH; Meyers CA; Tansey LW; Payne R; Levin VA
Cytokine; 1994 Jul; 6(4):365-7. PubMed ID: 7948743
[TBL] [Abstract][Full Text] [Related]
4. Role of dopamine in d-amphetamine-induced discriminative responding.
Ho BT; Huang JT
Pharmacol Biochem Behav; 1975; 3(6):1085-92. PubMed ID: 1223898
[TBL] [Abstract][Full Text] [Related]
5. CGS 10746B is able to attenuate the effects of amphetamine: further evidence for dopaminergic mediation.
Schechter MD; Boja JW
Pharmacol Biochem Behav; 1988 Aug; 30(4):1089-92. PubMed ID: 2906435
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha reinstates morphine-conditioned place preference through opioid receptors in rats.
Lang JY; Wang JS; Zhai HF; Fang Q; Wu P; Lu L
Behav Pharmacol; 2009 Mar; 20(2):166-73. PubMed ID: 19322075
[TBL] [Abstract][Full Text] [Related]
7. Modification of d-amphetamine- or chlorpromazine-induced hypothermia by beta-endorphin, MIF-I, and alpha-MSH: mediation by the dopaminergic system.
Yehuda S; Carasso RL
Peptides; 1982; 3(2):105-10. PubMed ID: 6124951
[TBL] [Abstract][Full Text] [Related]
8. Effects of d-amphetamine, morphine, naloxone, and drug combinations on visual discrimination in rats.
Andrews JS; Holtzman SG
Psychopharmacology (Berl); 1988; 94(2):172-7. PubMed ID: 3127842
[TBL] [Abstract][Full Text] [Related]
9. Stimulus effects of d-amphetamine II: DA, NE, and 5-HT mechanisms.
West WB; Van Groll BJ; Appel JB
Pharmacol Biochem Behav; 1995 May; 51(1):69-76. PubMed ID: 7617735
[TBL] [Abstract][Full Text] [Related]
10. gamma-Endorphin and N alpha-acetyl-gamma-endorphin interfere with distinct dopaminergic systems in the nucleus accumbens via opioid and non-opioid mechanisms.
van Ree JM; Gaffori O; Kiraly I
Life Sci; 1984 Apr; 34(14):1317-24. PubMed ID: 6200747
[TBL] [Abstract][Full Text] [Related]
11. Comparative discriminative stimulus properties of dl-cathinone, d-amphetamine, and cocaine in rats.
Huang D; Wilson MC
Pharmacol Biochem Behav; 1986 Feb; 24(2):205-10. PubMed ID: 3952111
[TBL] [Abstract][Full Text] [Related]
12. Stimulus properties of d-amphetamine as compared to l-amphetamine.
Schechter MD
Eur J Pharmacol; 1978 Feb; 47(4):461-4. PubMed ID: 631192
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the discriminative stimulus properties of clonidine and amphetamine in rats.
D'Mello GD
Neuropharmacology; 1982 Aug; 21(8):763-9. PubMed ID: 7121748
[TBL] [Abstract][Full Text] [Related]
14. Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue.
Furmidge LJ; Exner M; Clark D
Eur J Pharmacol; 1991 Sep; 202(2):191-9. PubMed ID: 1687032
[TBL] [Abstract][Full Text] [Related]
15. Effects of nikethamide, picrotoxin and strychnine on 'amphetamine-state'.
Huang JT; Ho BT
Eur J Pharmacol; 1974 Nov; 29(1):175-8. PubMed ID: 4471362
[No Abstract] [Full Text] [Related]
16. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
Minnema DJ; Rosecrans JA
Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
[TBL] [Abstract][Full Text] [Related]
17. Lack of blockade of central dopaminergic receptors by narcotics: comparison with chlorpromazine.
Schechter MD
Eur J Pharmacol; 1978 Jun; 49(3):279-84. PubMed ID: 658141
[TBL] [Abstract][Full Text] [Related]
18. Effects of d- and l-amphetamine on food intake: evidence for a dopaminergic substrate.
Evans KR; Vaccarino FJ
Pharmacol Biochem Behav; 1987 Aug; 27(4):649-52. PubMed ID: 3659091
[TBL] [Abstract][Full Text] [Related]
19. Amphetamine discrimination as a test for anti-parkinsonism drugs.
Schechter MD
Eur J Pharmacol; 1977 Jul; 44(1):51-6. PubMed ID: 885158
[TBL] [Abstract][Full Text] [Related]
20. Gamma-butyrolactone's discriminability and effect on low rates of lever pressing by rats: alone and in combination with D-amphetamine and naloxone.
McIntire KD; Cleary J; Weinfurter S
Pharmacol Biochem Behav; 1988 May; 30(1):45-53. PubMed ID: 3174754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
